Divis Labs soars 8 percent as USFDA closes out warning letter on Vizag unit Ruby Khatun Khatun12 Nov 2017 10:01 AM ISTNew Delhi: Shares of Divis Laboratories jumped as much as 8 percent to an intraday high of Rs. 1,089.90 against the previous close of Rs. 1,009.75 as...
Merck KGaA has contacted prospective buyers of consumer health Ruby Khatun Khatun12 Nov 2017 9:45 AM ISTFRANKFURT: Germany’s Merck KGaA said it has sent information documents on its consumer health business to prospective buyers, kicking off an auction,...
AstraZeneca rides China wave as rival GlaxoSmithKline struggles Ruby Khatun Khatun12 Nov 2017 9:30 AM ISTLONDON: AstraZeneca is enjoying booming drug sales in China, helped by reforms to the country’s regulatory system and an increased sales force, in...
Hikma, Vectura in dispute with FDA over generic Advair Ruby Khatun Khatun12 Nov 2017 9:00 AM ISTLONDON: Hikma and its partner Vectura are in dispute with the Food and Drug Administration over their plans to launch a generic copy of...
CGHS medicine supplier SURRENDERS Rs 200 crore black money Ruby Khatun Khatun11 Nov 2017 12:46 PM ISTNew Delhi: One of the biggest suppliers of medicines to Central Government Health Scheme (CGHS) hospitals "surrendered" Rs 200 crore he allegedly held...
Aurobindo Pharma Q2 net up 29 percent at Rs 780.97 crore Ruby Khatun Khatun11 Nov 2017 10:47 AM ISTNew Delhi: Drug firm Aurobindo Pharma reported a 28.96 percent rise in its consolidated net profit to Rs 780.97 crore for the September quarter of the...
Zydus gets regulatory nod to market Lipaglyn in Mexico Ruby Khatun Khatun11 Nov 2017 10:32 AM ISTNew Delhi: Drug firm Zydus said it has received approval from the Mexican regulatory authority to market Lipaglyn (Saroglitazar Magnesium) used for...
Morepen Labs ties up with Vesale Pharma of Belgium Ruby Khatun Khatun11 Nov 2017 10:32 AM ISTNew Delhi: Morepen Laboratories Ltd. entered into a tie-up with Vesale Pharma International of Belgium to strengthen its position in the Rs. 1000...
Alkem Labs Q2 Net up 14 percent at Rs 327.44 crore Ruby Khatun Khatun11 Nov 2017 10:16 AM ISTNew Delhi: Drug firm Alkem Laboratories reported a 13.63 percent rise in consolidated net profit at Rs 327.44 crore for the quarter ended September 30...
FDA OKs Merck drug that prevents infection post-stem cell transplant Ruby Khatun Khatun11 Nov 2017 10:01 AM ISTMerck & Co Ltd's drug to prevent serious infection in patients who undergo a type of stem cell transplant was approved by the U.S. Food and Drug...
Dynavax hepatitis B vaccine gets FDA nod on third try, shares up Ruby Khatun Khatun11 Nov 2017 9:45 AM ISTDynavax Technologies Corp's hepatitis B vaccine won the U.S. Food and Drug Administration's approval on the third attempt and Chief Executive Eddie...
Regeneron third-quarter profit easily tops Street view on Eylea, Dupixent sales Ruby Khatun Khatun11 Nov 2017 9:30 AM ISTRegeneron Pharmaceuticals Inc on Wednesday reported third-quarter profit that sailed past Wall Street estimates on the strength of increased demand...
